Due to the association of PAK4 positivity with the survival of osteosarcoma patients receiving adjuvant chemotherapy, we investigated the effects of PAK4 on osteosarcoma under treatment with doxorubicin. This evidence concerns the gene PAK4 and osteosarcoma.